The FDA has cleared Lucilia cuprina larvae for use in maggot debridement therapy.

The FDA has cleared Lucilia cuprina larvae for use in maggot debridement therapy.

The US Food and Drug Administration has cleared Medifly Maggots, a prescription wound-care product from Singapore-based Cuprina, for use in maggot debridement therapy.